TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Animal Or Human Proteins, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Animal Or Human Proteins technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Animal Or Human Proteins

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Industry Landscape Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Animal Or Human Proteins industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Animal Or Human Proteins industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Animal Or Human Proteins industry

Composition Comprising Micellar Whey Protein, Vitamin D And Clacium To Improve Or Maintain MuscleSOCIT DES PRODUITS NESTLJun 24, 2025FRESENIUS KABI DEUTSCHLAND
Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENEMay 7, 2025MAIWALD
Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENEMay 5, 2025WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 12, 2025MAIWALD
Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 10, 2025WUESTHOFF & WUESTHOFF
Methods For Treating Myelodysplastic Syndromes And Sideroblastic AnemiasACCELERON PHARMADec 20, 2024WUESTHOFF & WUESTHOFF
Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 13, 2024GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 12, 2024SANDOZ
Insulinotropic And Glucagonotropic Effects Of Beta-LactoglobulinARLA FOODS AMBANov 14, 2024ZIMMERMANN & PARTNER PATENTANWALTE MBB
Insulinotropic And Glucagonotropic Effects Of Beta-LactoglobulinARLA FOODS AMBANov 13, 2024NUTRICIA

To stay ahead in the competitive Animal Or Human Proteins industry, companies are constantly innovating. Here are the top patents facing oppositions in the Animal Or Human Proteins industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Nov 3, 2021SyringeNOVARTIS7
Jan 5, 2022Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization LesionBAYER HEALTHCARE6
Apr 19, 2023Method For Producing Fusion Protein Having Igg Fc DomainALTEOGEN4
Oct 26, 2022Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSTEOQC4
Aug 10, 2022Use Of A Vegf Antagonist To Treat Angiogenic Eye DisordersREGENERON PHARMACEUTICALS4
Sep 14, 2022Liquid Enteral Nutritional Composition With A Low Monovalent Metal Ion ContentNUTRICIA4
Nov 21, 2018Antibodies And Vaccines For Use In Therapeutic And Diagnostic Methods For Alpha-Synuclein-Related DisordersBIOARCTIC NEUROSCIENCE3
Mar 13, 2024Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICAL3
Apr 22, 2020Improved Methods For Manufacturing Adoptive Cell TherapiesSEVENTY BIO3
Jan 27, 2021Vegf Antagonist Formulations Suitable For Intravitreal AdministrationREGENERON PHARMACEUTICALS3